Lightning Stick for Attention Deficit Hyperactivity Disorder (ADHD)

"Patients aged between 7 and 16 years old are being sought after for inclusion in this medical trial."

"As per the information on clinicaltrials.gov, this study is presently accepting participants. This trial was initially posted to the database on August 1st 2022 and has been recently modified as of October 21st 2022."

"Indeed, the current information available on clinicaltrials.gov attests that this research is presently recruiting participants. Originally posted in August of 2022, it was most recently updated at the end of October and requires 15 individuals to be recruited across 1 site."

"The primary outcome of this clinical trial, that will be monitored over week 6, is to measure the Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale. Additionally, secondary outcomes are measured regarding acceptability, feasibility and preference; these include acceptance if more than 70% of children and parents express their liking for an at-home dried urine sample collection method as opposed to lab tests (Acceptabilty), blood samples provided using the Tasso device by more than 70% of participants (Feasibility 1), and dried urine samples collected from greater than or equal to 70% of participants (Fe"

"This trial is recruiting 15 minors aged 7 to 16 with Attention Deficit Disorder. To be eligible, these participants must meet the criteria: age between seven and sixteen years at enrollment, vocal agreement to take one EmpowerPlus Lightning Stick daily, attendance of all virtual sessions and completion of questionnaires, participation in a pre-existing multinutrient study or successful screening for comparable symptoms and age cohort; suspension of medication/supplementation prior to commencement (excluding those contained within the Lightning Stick), collection of single blood/urine sample from home."